NGM Bio Announces Plans for a New Clinical Trial
NGM Bio has announced plans for a new clinical trial to evaluate a medicine called aldafermin in PSC.
Read MorePrivacy Policy Update 29 July 2024
We’ve updated our Privacy Policy
Read MorePositive Results Announced from SPRING Trial
Positive results from the SPRING Clinical Trial announced today
Read MoreFirst Participant in FARGO Trial
A PSC Support Trustee has been diagnosed with both PSC and inflammatory bowel disease (IBD). They is receiving weekly poo transplants to treat the conditions in a world first trial.
Read MoreOutpatient: Solo Comedy at Edinburgh Festival
PSC Patient prepares to perform her first solo comedy at Edinburgh Festival Fringe
Read MoreOlympic Games 2024 Sweepstake
Go for gold by hosting an Olympic Games sweepstake with friends, family or colleagues. Celebrate sport and cheer on Team GB all while helping us find the breakthrough people with PSC so desperately need.
Read MoreMore Encouraging Data from the INTEGRIS Clinical Trial
Pliant Therapeutics announce latest results from the INTEGRIS Clinical Trial
Read MoreDr Andrew Yeoman joins our Scientific Review Committee
We are delighted to announce that Dr Andrew Yeoman has joined our Scientific Review Committee
Read MoreMore Mission 2030 Research Announced
PSC Support has awarded £52,500 to Dr Anthony George to uncover the processes that drive inflammation and damage in PSC.
Read MoreKieron Dyer’s PSC Journey
Footballing legend Kieron Dyer shares his PSC journey, talking diagnosis, life with PSC, liver transplantation and recovery
Read More